Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Svp, Chief Technical Officer
-
Stock Symbol
-
HALO on Nasdaq
Michael J. LaBarre - trading volume in the past year for Halozyme Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
174K |
$10.2M |
$58.74 |
Feb 27, 2025 |
Direct |
|
|
| Option to Purchase Common Stock |
11.7K |
$945K |
$13.87 |
Jun 18, 2024 |
Direct |
Common Stock |
|
| Restricted Stock Units |
14.2K |
$822K |
$57.75 |
Feb 23, 2025 |
Direct |
Common Stock |
|
| Performance Stock Unit |
4.92K |
$278K |
$56.41 |
Feb 12, 2025 |
Direct |
Common Stock |
|
| Option to Purchase Common Stock |
11.9K |
$165K |
$13.87 |
Feb 20, 2025 |
Direct |
Common Stock |
|
| Performance Stock Units |
0 |
$0 |
$58.29 |
Feb 16, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.